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ABSTRACT
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is a common cause of euvolemic hyponatremia which has many 
possible etiologies such as tumors (mainly lung cancers). We present a case of a 79-year old women hospitalized due to microcytic anemia 
with transfusion need and hyponatremia due to SIADH. Three primary tumors without known metastasis were discovered. The case shows 
the importance of studying causes of hyponatremia. 
LEARNING POINTS
• Hyponatremia is a common electrolytic disorder during hospitalization and is associated with greater mortality.
• Correction of hyponatremia, cause can be devastating unless the underlying causes are investigated as it can be caused by severe 
diseases .
• Cancer must be excluded in the absence of an obvious etiology of SIADH (drugs, pulmonary and nervous system disorders).
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INTRODUCTION
SIADH is a major cause of hypotonic hyponatremia with normal extracellular fluid volume and is characterized by hyponatremia, plasma 
osmolality <275mOsm/kg, urine osmolality >100 mOsm/kg, urine sodium concentration >30mmol/l, and low serum urea and uric acid in the 
absence of other causes (diuretics, adrenal and thyroid insufficiency)[1]. It could be due to malignant diseases, drugs, or pulmonary or nervous 
system disorders[2]. Tumoral hyponatremia is more common in small-cell lung cancer than other solid and hematological malignancies[3]. 
Besides some study heterogeneity, hyponatremia seems to be a negative prognostic factor in cancer patients[4]. Management of hyponatremia 
includes fluid restriction, saline infusion, and/or drugs (furosemide, urea and vasopressin receptor antagonists)[5].
CASE REPORT
This case is a 79-years old Caucasian woman with a history of hypertension (treated with irbesartan), type 2 diabetes (treated with 
metformin, glimepiride, and sitaglitin) and microcytic anemia hospitalized for hyponatremia (119nmol/L) and worsening anemia with red 
cell concentrates transfusion need (Hb 5.7g/dL). The patient had asthenia, anorexia, and dizziness, and denied nausea, vomiting, melena, 
hematochezia, metrorrhagia, excessive water ingestion, and changes in weight.
On admission, patient had pale skin, tachycardia (110 bpm), pulmonary auscultation was normal, her abdomen was soft and without palpable 
masses or organomegaly. She did not have dry skin or edema. 
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Initial blood test results: hemoglobin 5.7mg/dL (12-15), mean corpuscular volume 67.1fL (80-96), mean corpuscular hemoglobin 25.3pg 
(27.3-37.3), platelets 515x109/L (150-400), serum creatinine 0.77mg/dL (0.5-0.9), sodium 119mmol/L (136-145), chloride 88mmol/L (98-
107), potassium 5.1mmol/L (3.5-5.1), normal transaminases, c-reactive protein 9mg/dL (<0.5). The hyponatremia study is shown in Table 1.
Table 1. Hyponatremia study
Euvolemic hyponatremia was diagnosed. After exclusion of hypothyroidism, suprarenal insufficiency, and in the absence of diuretics, 
the relatively high urinary osmolality (>300) and sodium (>30) for the level of serum sodium and plasmatic osmolality confirmed the 
diagnosis of SIADH but there was no clear etiology. None of the drugs the patient used were linked to SIADH. A gastrointestinal tract 
tumor was suspected due to microcytic anemia so an endoscopy and a colonoscopy were planned. Meanwhile, chest radiograph revealed a 
heterogeneous hypotransparency in the right hemithorax medium third (Fig. 1). A chest tomography was performed to clarify this finding 
which showed a single right lung mass, suggesting primary cancer. Tumoral marker tests were within reference range (CA 12.9 13U/mL, 
Neuron-specific enolase 7.8ng/mL, squamous cell carcinoma antigen 0.9ng/mL, CEA 4.3ng/mL). 
In spite of the strongly suspected lung cancer, which is a common tumoral cause of SIADH, it was decided to continue the investigation 
because the cause of the microcytic anemia was as yet unclear. Endoscopy showed a gastric mass. Colonoscopy was also performed 
and revealed a cecal mass (Fig. 2), suggesting primary colon tumor. A biopsy by fibrobronchoscopy confirmed a poor differentiated lung 
adenocarcinoma, also suggesting primary tumor. Therefore, three possible primary tumors were discovered in the SIADH investigation. 
Patient had a good performance status so surgery was planned (divided in two phases, first colon plus stomach, then pulmonary).
During the extensive workup, the patient had fluid restriction and started furosemide, but symptomatic hyponatremia sustained. She started 
oral therapy of urea 30g/day. Sodium remained stable within reference range until surgery. The evolution of sodium after hospitalization is 
shown in Figure 3.
Abdominal surgery composed of right hemicolectomy and partial gastrectomy was performed 4 weeks after initial hospitalization. 
Histopathological study confirmed GIST tumor (T2) and cecum adenocarcinoma (pT3, N1c). The patient died fifteen days after surgery due 
to a hospital infection before the final surgery could be carried out.
Patient Reference range
Creatinine (mg/dL) 0.77 0.5-0.9
Na+ (mmol/L) 145 135-145
K+ (mmol/L) 3,92 3,5-5,2
Plasma osmolality (mOsmol/L) 260 275-295
Urinary osmolality (mOsmol/L) 346 300-900
Urinary sodium (mmol/L) 88 40-220
Morning serum cortisol (mcg/dL) 32.3 6.2-19.4
TSH (uU/mL) 2.23 0,4 -4
Uric acid (mg/dL) 3.0 2.4-5.7
Glucose (mg/dL) 214 74-106
Figure 1. Serum sodium (mmol/L) evolution during hospitalization. Serum 
sodium (mmol/L) evolution during hospitalization. (A) Patient started fluid 
re-striction and furosemide; (B) Urea 30g/day was initiated; (C) Surgery – 
hemicolectomy and partial gastrectomy; (D) Urea was stopped in the intensive 
care due to hypernatremia.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2017_000594 European Journal of Case Reports in Internal Medicine © EFIM 2017
Figure 2. Right lung hypotransparency in chest radiography Figure 3. Colon tumor in colonoscopy
DISCUSSION
A case of euvolemic hyponatremia caused by SIADH is presented. Fluid restriction and furosemide were used to control sodium before 
treating the primary cause. It was not sufficient so urea 30g/day with normalization of sodium was started. Extensive workup was needed 
to clarify the SIADH etiology. Lung tumors, particularly small-cell lung cancer are the most common causes of tumoral SIADH. A lung mass 
strongly suspected of primary lung tumor was initially found. Normally this would be enough to complete the SIADH study. However, it 
did not explain the microcytic anemia with transfusion need. A gastrointestinal tumor due to microcytic anemia was suspected from the 
start. There could also be another gastrointestinal cause of anemia due to blood loss, potentially treatable (such as peptic ulcer bleeding, 
angiodysplasia, or bleeding colon polyp), so it was decided to continue the investigation finding GIST and colon carcinoma. This would not 
have been done in the absence of severe microcytic anemia. 
Consequently, this was an unusual setting of three primary tumors without known metastasis confirmed in histopathological study. It 
is difficult to say which tumor was causing the SIADH so possibly more than one. However, , besides the limitation of surgery losses and 
posterior fluid management, analyzing the evolution of sodium shows that SIADH was not resolved so the lung tumor could still have 
produced antidiuretic hormone.
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